Clinical studies recruiting near Saint Herblain

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/Phase 2 · Tango Therapeutics, Inc. · NCT05732831 Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype
Phase 3 · University Hospital, Tours · NCT05732727 To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemothe
NA · Institut Cancerologie de l'Ouest · NCT06800989 Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Phase 2 · UNICANCER · NCT07661927 CARE1 Pragmatic Clinical Trial
Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris · NCT06364631 Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy f
Phase 3 · Federation Francophone de Cancerologie Digestive · NCT06207981 Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 · SystImmune Inc. · NCT05983432 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Bayer · NCT06452277 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Mirati Therapeutics Inc. · NCT04613596 Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
Phase 3 · Centre Francois Baclesse · NCT04290663 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · OSE Immunotherapeutics · NCT06472245 Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clini
Phase N/A · Assistance Publique - Hôpitaux de Paris · NCT06916481 Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomark
NA · Institut Claudius Regaud · NCT05378204 Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk
NA · UNICANCER · NCT07187726 Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Phase 3 · European Organisation for Research and Treatment of Cancer - · NCT05904119 Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
Phase 2 · UNICANCER · NCT06529718 Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
Phase 1 · Gilead Sciences · NCT04617522 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Gilead Sciences · NCT05633654 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colo
Phase 3 · Seagen, a wholly owned subsidiary of Pfizer · NCT05253651 FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Phase 1/Phase 2 · Pierre Fabre Medicament · NCT06669117 Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Adv
Phase 2/Phase 3 · Eikon Therapeutics · NCT06697301 Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Phase 1 · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · NCT06625775 A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors
Phase 1 · Daiichi Sankyo · NCT07015697 Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer
NA · Institut Claudius Regaud · NCT06588322 First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations i
Phase 1/Phase 2 · Bayer · NCT05099172 Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced
Phase 4 · Institut Claudius Regaud · NCT07195344

Look up another city

Look up another condition